NAD+ Pen vs Pills vs IV: Absorption Compared

An in-depth look at NAD+ bioavailability across oral supplements, IV drips, and the subcutaneous Holte NAD+ Pen—so busy, health-conscious professionals can choose the best NAD+ delivery method.

Key takeaways

Bioavailability = how much active ingredient reaches your system. Route matters.
Oral NAD+ precursors (e.g., NR/NMN) can raise blood NAD+ but are limited by GI/first-pass metabolism; responses vary person-to-person.
IV NAD+ delivers directly to circulation (by definition, highest systemic delivery) but requires clinic time and cost.
Subcutaneous (SC) delivery with the NAD+ Pen bypasses first-pass metabolism and supports high, steady systemic availability without a clinic visit.
For many busy professionals, the Holte NAD+ Pen offers the best balance of absorption, convenience, and total cost of use.

What is NAD+ bioavailability, really?

NAD+ bioavailability describes how much of an NAD+-related dose your body actually absorbs and can use. Oral routes face barriers like digestive breakdown and first-pass metabolism in the liver, while parenteral routes (IV and subcutaneous) bypass many of those hurdles. Choosing the most effective NAD+ supplement is largely about choosing the right delivery method.

Three delivery routes, three absorption profiles

1) Oral NAD+ precursors (pills/capsules)

How it works: You swallow a precursor (commonly nicotinamide riboside, NR, or nicotinamide mononucleotide, NMN). It’s absorbed through the gut, processed by the liver, and contributes to the body’s NAD+ pool.

Bioavailability & effect: Oral NR can raise blood NAD+ levels (e.g., ~35–168% in small human studies; single-dose outliers up to ~2.7×). Responses vary due to GI transport and metabolism.
Pros: Simple, familiar, travel-friendly; good entry point.
Cons: Lower/variable NAD+ bioavailability vs parenteral routes; daily adherence needed.
Best for: People happy with steady, modest increases and a “set-and-forget” routine.

2) IV NAD+ drips

How it works: NAD+ is infused directly into the bloodstream in a clinic (typically multi-hour sessions).

Bioavailability & effect: IV delivery is the systemic reference standard (no first-pass metabolism). Pilot human data show substantial rises in plasma NAD+ by the end of a prolonged infusion.
Pros: Maximal systemic delivery; rapid peak levels.
Cons: Clinic time, cost, needles, scheduling; effects can be “spiky.”
Best for: Those wanting supervised infusions and don’t mind clinic visits.

3) Subcutaneous (SC) NAD+ with the Holte NAD+ Pen

How it works: Small, at-home subcutaneous micro-injections deposit NAD+ solution into the fat layer beneath the skin for gradual uptake into circulation.

Bioavailability & effect: SC delivery bypasses first-pass metabolism and generally achieves high systemic availability across many molecules, with steadier absorption than IV bolus and stronger systemic availability than oral.
Pros: Convenient, clinic-free, steady kinetics, time-efficient, travel-friendly.
Cons: Requires simple technique training; mild, temporary injection-site sensations possible.
Best for: Busy professionals and early adopters seeking high-absorption NAD+ Pen use at home.

NAD+ Pen vs pills vs IV: side-by-side comparison

Delivery	How it works	Bioavailability & kinetics	Pros	Cons	Best for
Oral (NR/NMN)	Swallowed; absorbed via gut; processed by liver	Variable increase in blood NAD+ (study ranges ~35–168% over baseline; single-case up to ~2.7×). Subject-to-subject variability.	Simple, low friction	First-pass metabolism reduces systemic availability; daily dosing	Steady, modest support; pill-first users
IV NAD+	Direct infusion into bloodstream	Systemic delivery without first-pass; marked plasma rise by end of multi-hour infusion; clinic-based	Maximal systemic delivery; rapid peaks	Time-consuming, costly, invasive	Supervised, episodic boosts
SC NAD+ Pen	Tiny at-home micro-injections into subcutaneous layer	Bypasses first-pass; generally high systemic availability across molecules; steady absorption profile	High bioavailability without clinic visits; flexible timing; travel-friendly	Basic technique needed; minor site sensations	Busy professionals & early adopters wanting the most effective NAD+ delivery method at home

Note: “Bioavailability” is molecule- and person-specific. Figures above summarize route characteristics from pharmacokinetics literature; they are not disease claims.

For the Health-Conscious Early Adopter

Want measurable Holte NAD+ Pen efficacy without clinic time? SC delivery supports NAD+ Pen absorption while fitting a modern longevity routine.

For the Busy Professional

Prefer results with minutes, not hours? The Pen provides a high-bioavailability NAD+ option you can use before a workout, big meeting, or flight.

How to choose the best NAD+ delivery method

Prioritise bioavailability: If oral hasn’t moved the needle, consider SC or IV.
Factor time & cost: IV = clinic + higher cost; SC Pen = home use + lower total burden.
Think lifestyle fit: Consistency beats occasional spikes, SC often wins for routine performance.
Start simple: Begin with the Pen; layer oral precursors as desired; reserve IV for supervised boosts.

Shop Holte NAD+ Pen

Subscribe to high-bioavailability NAD+ cartridges

Looking for buy high bioavailability NAD+? You’re in the right place.

FAQs

Is oral NAD+ the same as IV or a subcutaneous NAD+ Pen?

No. Oral NAD+ usually means precursors (NR/NMN) that raise NAD+ indirectly and variably. IV and subcutaneous routes bypass first-pass metabolism, improving systemic delivery.

What’s the best NAD+ delivery method for bioavailability?

IV is the systemic reference standard but requires clinic time. Subcutaneous delivery via the NAD+ Pen provides high bioavailability with at-home convenience—often the most practical choice for ongoing use.

Will the Holte NAD+ Pen improve energy, focus, or recovery?

Many users choose higher-absorption routes to support performance routines. Individual responses vary; use as directed and consult a clinician if you have medical conditions or take medications.

Disclaimer: This educational guide does not diagnose, treat, or prevent disease. Speak with a qualified healthcare professional before making changes to your supplement routine.

References

Airhart SE et al. PLOS One, 2017. Oral NR increased whole-blood NAD+ (~35–168% across subjects). DOI:10.1371/journal.pone.0186459
Trammell SA et al. Nature Communications, 2016. Single-dose NR raised human blood NAD+ up to ~2.7× in a pilot subject.
Grant R et al. Frontiers in Aging Neuroscience, 2019. Multi-hour IV NAD+ infusion substantially increased plasma NAD+ by end of infusion.
StatPearls: Drug Bioavailability & First-Pass Effect (accessed 2023–2025). Parenteral routes bypass first-pass metabolism; IV is systemic reference.
Bittner B et al. BioDrugs, 2018 & TLCR 2024 review. Subcutaneous delivery: patient-preferred, high systemic availability across molecules vs IV (100%).

Your cart is currently empty.